article thumbnail

Short-term outpatient follow-up of vericiguat treatment in patients hospitalized for heart failure

Frontiers in Cardiovascular Medicine

BackgroundVericiguata novel oral soluble guanylate cyclase stimulatorwas developed for the treatment of chronic heart failure (HF). We matched 75 external control patients for this purpose.

article thumbnail

Finerenone and Outpatient Worsening Heart Failure With Mildly Reduced or Preserved Ejection Fraction

JAMA Cardiology

This secondary analysis of the Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in Patients With Heart Failure (FINEARTS-HF) randomized clinical trial evaluates the effect of finerenone on outpatient worsening heart failure events requiring oral diuretic intensification among patients with heart failure with mildly reduced or (..)

article thumbnail

Outpatient worsening of heart failure and mortality in transthyretin amyloid cardiomyopathy

European Journal of Heart Failure

Breakdown of the study population by worsening heart failure (WHF) event proportions (oral diuretic intensification or heart failure [HF] hospitalization) and KaplanMeier curve of all-cause mortality after WHF event shown, relative to a patient group that did not have any WHF events.

article thumbnail

Advance in the Treatment of Acute Heart Failure Identified

DAIC

Getty Images milla1cf Tue, 04/30/2024 - 12:56 April 30, 2024 — A multicenter study led by Vanderbilt University Medical Center ( VUMC ) and Lipscomb University College of Pharmacy in Nashville has identified a potential new treatment for acute heart failure , a leading cause of hospitalization and death. hospitals from emergency rooms.

article thumbnail

Research study shows the cost-effectiveness of AI-enhanced heart failure screening

Science Daily - Heart Disease

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings suggest that this type of screening is also cost-effective in the long term, especially in outpatient settings.

Research 123
article thumbnail

BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study

DAIC

CMS has reviewed the CardiAMP Heart Failure II Trial and approved the investigational product, related and routine items and services for purposes of Medicare coverage. The CardiAMP Heart Failure II Trial is FDA approved to enroll up to 250 patients at up to 40 clinical centers. said Peter Altman , PhD.,

CMS 111
article thumbnail

Heart Failure Patients Who Do Yoga Have Stronger Hearts and Can be More Active

DAIC

milla1cf Tue, 05/28/2024 - 07:00 May 28, 2024 — Yoga focused on breathing, meditation, and relaxation is linked with symptom improvement in patients with heart failure, according to research presented at Heart Failure 2024 , a scientific congress of the European Society of Cardiology (ESC).